688266.SS
Price:
$144.55
Market Cap:
$38.26B
Suzhou Zelgen Biopharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, and distribution of medicines in the People's Republic of China. The company offers donafenib tablets for hepatocellular carcinoma and iodine-refractory differentiated thyroid cancer; recombinant human thrombin for hemostasis; and jacktinib tablets for intermediate and high-risk myelofibrosis. It also develops drug candidates in the NDA, Phase III, or registration clinical trial stages, such as gecacitinib hydrochloride tablets for severe alopecia areata, moderate to severe atopic dermatitis, ankylosing spondylitis, ruxolitinib-intolerant and relapsed/refractor...[Read more]
Industry
Biotechnology
IPO Date
2020-01-23
Stock Exchange
SHH
Ticker
688266.SS
According to Suzhou Zelgen Biopharmaceuticals Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -236.64. This represents a change of 53.04% compared to the average of -154.63 of the last 4 quarters.
The mean historical PE Ratio of Suzhou Zelgen Biopharmaceuticals Co., Ltd. over the last ten years is -112.62. The current -236.64 PE Ratio has changed 20.91% with respect to the historical average. Over the past ten years (40 quarters), 688266.SS's PE Ratio was at its highest in in the March 2026 quarter at 10.33. The PE Ratio was at its lowest in in the September 2025 quarter at -384.91.
Average
-112.62
Median
-39.42
Minimum
-678.09
Maximum
0
Discovering the peaks and valleys of Suzhou Zelgen Biopharmaceuticals Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = 0%
Minimum Annual PE Ratio = -678.09
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -149.52 | 24.78% |
| 2024 | -119.83 | 144.41% |
| 2023 | -49.03 | 124.56% |
| 2022 | -21.83 | -30.20% |
| 2021 | -31.28 | -34.25% |
| 2020 | -47.57 | 63.89% |
| 2019 | -29.02 | -95.72% |
| 2018 | -678.09 | -Infinity% |
| 2017 | 0 | 0% |
The current PE Ratio of Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-106.12
5-year avg
-74.30
10-year avg
-112.62
Suzhou Zelgen Biopharmaceuticals Co., Ltd.’s PE Ratio is less than Shijiazhuang Yiling Pharmaceutical Co., Ltd. (20.09), less than Hualan Biological Engineering Inc. (27.18), less than Xiamen Amoytop Biotech Co., Ltd. (22.48), less than Sinocelltech Group Limited (-18.40), less than Asymchem Laboratories (Tianjin) Co., Ltd. (53.16), less than Staidson (Beijing) BioPharmaceuticals Co., Ltd. (-135.55), less than Zhejiang Huahai Pharmaceutical Co., Ltd. (68.54), less than Shanghai Junshi Biosciences Co., Ltd. (-57.14), greater than Kangmei Pharmaceutical Co., Ltd. (-1444.44), less than DaShenLin Pharmaceutical Group Co., Ltd. (16.00),
| Company | PE Ratio | Market cap |
|---|---|---|
| 20.09 | $27.52B | |
| 27.18 | $23.59B | |
| 22.48 | $22.76B | |
| -18.40 | $17.05B | |
| 53.16 | $55.05B | |
| -135.55 | $11.20B | |
| 68.54 | $25.21B | |
| -57.14 | $37.82B | |
| -1444.44 | $17.98B | |
| 16.00 | $20.59B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Suzhou Zelgen Biopharmaceuticals Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Suzhou Zelgen Biopharmaceuticals Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Suzhou Zelgen Biopharmaceuticals Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS)?
What is the highest PE Ratio for Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS)?
What is the 3-year average PE Ratio for Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS)?
What is the 5-year average PE Ratio for Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS)?
How does the current PE Ratio for Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) compare to its historical average?